Investors, corporate development, and diligence teams
Financing rounds and ownership from SEC filings, pipeline, patent exposure, upcoming decisions and FDA enforcement history for a company, each traceable to its filing.
Individual plan, $249/seat/mo. Card required.
A first diligence pass means EDGAR for ownership and financing, ClinicalTrials.gov for the pipeline, FDA databases for quality history and a patent search for timing. The company appears under a different legal name in each. The memo is due before the reconciliation is finished.
Pages marked free open without an account. The rest open in the product, starting with a 14-day trial.
Funding lists private placements and public offerings drawn from SEC filings, with NIH grants and SBIR/STTR awards alongside. A round's page shows its date, type and issuer. It adds the offering size where the filing states one and a link to the source filing on SEC EDGAR where one is on record.
In the product: Funding
A company's ownership page keeps insider holdings, beneficial owners, institutional managers' 13F positions and adviser control bands as separate records, each built from SEC filings. Where a panel is empty it states which sources were checked and what they held.
In the product: Ownership
Investors lists life-sciences investors by regulatory assets under management, from SEC Form ADV advisers with their private-fund rollup, alongside the NIH funding agencies. All of it is public-domain data.
In the product: Investors
The Financial and Ownership page reports figures taken from the company's SEC filings, such as public float, revenue, net income, R&D spend and total assets, with a link to the filing. These are the figures the company reported, with no analyst forecasts mixed in.
In the product: Companies
The Calendar is a dated list of upcoming FDA decisions, each drawn from public SEC 8-K and 6-K filings and tied to a drug and sponsor where the match holds up, which gives a holding's regulatory events a date. The Individual plan adds the licensed Benzinga catalyst calendar, shown with its attribution.
In the product: Calendar
FDA Enforcement collects inspections and Form 483s, warning and untitled letters, recalls, import refusals and debarments from public US FDA data, which gives a manufacturer's quality history a place in diligence. An item links to the organization's page when a record exists under that name.
In the product: FDA Enforcement
Ownership comes from SEC filings, so it covers companies and holders that file with the SEC, and an empty ownership panel says which sources were checked. The investor directory and funding history are still growing. Patent Cliff sizes exposure by the revenue a company discloses for a drug and, where none is disclosed, by US Medicare spend.
Every answer above marked "In the product" opens with the Individual plan.
Individual plan, $249/seat/mo, card required.
